T

Tort Reform Records

View All Tort Reform Records


Recent Tort Reform Records

S

State Tort Reform Enactments

View All State Tort Reform Enactments


Recent State Tort Reform Enactments

W

White Papers & Reports

View All White Papers & Reports


Recent White Papers & Reports

Local Legal Services Advertising Spending – Quarter 3, 2018

|2019

This study looks at seven media markets and dissects trial

[…]

This study looks at seven media markets and dissects trial lawyers’ spending on legal services ads in Los Angeles, San Francisco, Tampa-St. Petersburg, Miami-Ft. Lauderdale, St. Louis, Kansas City and New York City. It offers comparisons between Quarter 2 spending and Quarter 3 spending in 2018. Nearly 14 percent of all local legal services television ad spending occurred in these seven markets in the third quarter of 2018.


[hide]

View

Expert Opinions are member only content. Please contact us if you would like to become a member.

Become a Member
N

Recent Newsletters

A

Recent Amicus Briefs

Lindenberg v. Jackson National Life Insurance Co.

|6th Circuit|2019

(6th Circ., filed January 23, 2019): Supporting petition for en

[…]

(6th Circ., filed January 23, 2019): Supporting petition for en banc review, arguing that the panel’s ruling is inconsistent with Tennessee’s longstanding presumption of favoring constitutionality and history of upholding civil justice reforms.  The panel ruling also is contrary to the vast majority of state courts, which have upheld statutory limits on punitive damages, and relies on an outlier decision.  Also arguing that the ruling is contrary to every federal circuit court that has considered the constitutionality of a state limit on damages.


[hide]

Case not yet decided
View

Dolin v. GSK

|7th Circuit|2018

(7th Circuit,filed January 29, 2018): Arguing that the Court should

[…]

(7th Circuit,filed January 29, 2018): Arguing that the Court should reject the theory of innovator liability.


[hide]

Court ruled in favor of ATRA's position

On August 22, 2018, the 7th Circuit ruled that federal law preempted the plaintiff’s claim. GSK was barred from adding a warning about the risk of suicide. The court did not rule regarding innovator liability. 

View